Article
TRPM2 Channels: A Potential Therapeutic Target in Melanoma?
21 Jun 2023
Abstract excerpt
The transient receptor potential, the melastatin (TRPM) subfamily, which consists of eight known members, appears to have significant importance in melanoma progression, treatment, and prognosis. As several members were originally cloned from cancerous tissue, initial studies aimed towards identifying TRPM involvement in cancer progression and tumorigenesis. For relevance in skin cancer, previous research has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
